Recent Posts
Connect with:
Thursday / May 30.
HomeminewsHumphrey Field Analyzer 3: Now More Affordable

Humphrey Field Analyzer 3: Now More Affordable

Zeiss has increased its trade-in discount on all Humphrey Field Analyzer 3 (HFA3) models until 31 March 2023, making this valuable clinical device more affordable for practices.

Patients can often perceive visual field tests as the least desirable part of the glaucoma assessment, which can impact both the patient’s motivation to accurately perform their test and the likelihood of returning for follow-up visits.1

Zeiss has increased its trade-in discount on all Humphrey Field Analyzer 3 (HFA3) models until 31 March 2023

With SITA Faster’s reduced testing time of 30-50% on Humphrey Field Analyzer 3 (HFA3),2 perimetry tests can now be performed in as little as two minutes. Further, the 24-2C test can now better detect macular defects by testing ten additional points within the central 10 degrees that align with areas of known retinal nerve fibre bundles susceptible to glaucomatous defects. In some cases, central and peripheral glaucomatous changes can now be detected in just one test.3

For clinicians who value continuity in the Guided Progression Analysis (GPA) reports, the transition from legacy HFA2 devices will be seamless. Additionally, immediate adoption of the newest SITA Faster 24-2C strategy is possible in clinics that wish to adopt the above-mentioned testing strategies.

Upgrade to an HFA3

A generous increased trade-in discount is available on all HFA3 models until 31 March 2023.*

Clinics taking advantage of this opportunity will:
• Minimise patient testing time with SITA Faster,
• Increase clinical confidence with an additional 10 macular testing points of SITA Faster 24-2C, and
• Adopt new testing strategies but maintain continuity with the same GPA reports.

Contact: [email protected].

* Discuss eligibility with your registered tax advisor and refer to: www.ato.gov.au/Business/Depreciation-and-capital-expenses-and-allowances/Temporary-full-expensing.

1. Gardiner SK., Demirel S.. Assessment of patient opinions of different clinical tests used in the management of glaucoma. Ophthalmology. 2008 Dec;115(12):2127-31. doi: 10.1016/j.ophtha.2008.08.013. PMID: 19041473; PMCID: PMC3704561.
2. Heijl A et al. A new SITA perimetric threshold testing algorithm: Construction and a Multicenter Clinical Study. Am J Ophthalmol. 2019;198:154-165.
3. Chakravarti T., et al. Agreement between 10-2 and 24-2c visual field test protocols for detecting glaucomatous central visual field defects. J Glaucoma. 2021 Jun 1;30(6):e285-e291. doi:10.1097/IJG.0000000000001844. PMID: 33813563; PMCID: PMC8169576.